Cite
APA Citation
Kim, J., Nair, A., Keegan, P., Beaver, J. A., Kluetz, P. G., Pazdur, R., Chuk, M., & Blumenthal, G. M. (2020). evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs. Oncologist, 25, 348–354. http://access.bl.uk/ark:/81055/vdc_100103477759.0x000030